VACCINE COMPOSITIONS AND USES THEREOF

The present invention relates to vaccine compositions and uses thereof. Embodiments of the present invention provide oral bacterial (e.g., probiotic lactic acid bacteria) vaccine delivery systems comprising an antigen and a dendritic cell-targeting peptide. Such compositions target vaccines to dendr...

Full description

Saved in:
Bibliographic Details
Main Authors MOAHAMADZADEH MANSOUR, KLAENHAMMER TODD R
Format Patent
LanguageEnglish
Published 21.04.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract The present invention relates to vaccine compositions and uses thereof. Embodiments of the present invention provide oral bacterial (e.g., probiotic lactic acid bacteria) vaccine delivery systems comprising an antigen and a dendritic cell-targeting peptide. Such compositions target vaccines to dendritic cells, resulting in a high level of humoral and acquired immunity, including both mucosal and systemic immunity. Such delivery systems find use in the specific delivery of a wide variety of oral vaccines to subjects.
AbstractList The present invention relates to vaccine compositions and uses thereof. Embodiments of the present invention provide oral bacterial (e.g., probiotic lactic acid bacteria) vaccine delivery systems comprising an antigen and a dendritic cell-targeting peptide. Such compositions target vaccines to dendritic cells, resulting in a high level of humoral and acquired immunity, including both mucosal and systemic immunity. Such delivery systems find use in the specific delivery of a wide variety of oral vaccines to subjects.
Author KLAENHAMMER TODD R
MOAHAMADZADEH MANSOUR
Author_xml – fullname: MOAHAMADZADEH MANSOUR
– fullname: KLAENHAMMER TODD R
BookMark eNrjYmDJy89L5WRQDXN0dvb0c1Vw9vcN8A_2DPH09wtWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhoYGloYmlsaOhsbEqQIAHEsl-g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2011091493A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2011091493A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:41:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2011091493A13
Notes Application Number: US20100906428
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110421&DB=EPODOC&CC=US&NR=2011091493A1
ParticipantIDs epo_espacenet_US2011091493A1
PublicationCentury 2000
PublicationDate 20110421
PublicationDateYYYYMMDD 2011-04-21
PublicationDate_xml – month: 04
  year: 2011
  text: 20110421
  day: 21
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies NORTHWESTERN UNIVERSITY
RelatedCompanies_xml – name: NORTHWESTERN UNIVERSITY
Score 2.811396
Snippet The present invention relates to vaccine compositions and uses thereof. Embodiments of the present invention provide oral bacterial (e.g., probiotic lactic...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title VACCINE COMPOSITIONS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110421&DB=EPODOC&locale=&CC=US&NR=2011091493A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRJaDmFiRm0ySHIOkmIRXyoElKb2WTbECQWmzEv-9k22hPvS27MPtg5_HN7MwCPBo1Y6g6LMQm-kghJQJWkxk1Yp6SaNzizGJtRDeMRkFO3ub6vAcfXS6MqBP6I4ojIkeVyO-NkNerfyeWK95Wrp-Ld-z6fPUz25Wrzt2Hd1CV3bHtJbEbU5lSO0_laLoZsxAOaA5ipYPWkG4r7XuzcZuXstpVKv4pHCZIb9mcQY8vB3BMu7_XBnAUbkPe2Nxy3_ocnmYOpZPIk2gcJnE6ERnAkhO5Uo5SUcoCb-rF_gU8-F5GAwXnW_xtb5Gnu4vTLqGPwJ9fgaQjFtCMulJZiUa_UbDKNKyqqk0-IiUxzGsY7qN0s3_4Fk42_lGivKhD6Ddf3_wOFWxT3Itz-QXNH3nK
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDNrUjMJpscirSbhESbB21SegubFwhSi434952kjfbU27ILsw92Ht_MzizAAy04R9WhIzZR1AFJEbBqnBaIeVIi53rOdV5FdF1PtSPyulAWLfhocmHqOqE_dXFE5KgU-b2s5fXq34ll1G8r10_JO3Z9vljh0BCzxt2Hd1ASjfHQDHzDZyJjw2gmetPNmI5wQB4hVjqgVX3eyniaj6u8lNWuUrFO4DBAesvyFFr5sgsd1vy91oUjdxvyxuaW-9Zn8DgfMeZ4psB8N_BnTp0BLIw8Q4hQKgqhbU5N3zqHe8sMmT3A-eK_7cXRbHdx8gW0EfjnlyAoiAVkWmQST9HopwnPNKpnWaHlKkkJ1XrQ30fpav_wHXTs0J3EE8d7u4bjja-UDJ6lPrTLr-_8BpVtmdzWZ_QLp4p8tw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VACCINE+COMPOSITIONS+AND+USES+THEREOF&rft.inventor=MOAHAMADZADEH+MANSOUR&rft.inventor=KLAENHAMMER+TODD+R&rft.date=2011-04-21&rft.externalDBID=A1&rft.externalDocID=US2011091493A1